JP Morgan Chase’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-960,830
| Closed | -$3.79M | – | 6834 |
|
|
2021
Q1 | $3.79M | Sell |
960,830
-109,090
| -10% | -$353K | ﹤0.01% | 3209 |
|
|
2020
Q4 | $2.49M | Buy |
1,069,920
+40,441
| +4% | +$99.1K | ﹤0.01% | 3327 |
|
|
2020
Q3 | $2.14M | Buy |
1,029,479
+8,626
| +0.8% | +$20.1K | ﹤0.01% | 3177 |
|
|
2020
Q2 | $2.11M | Sell |
1,020,853
-43,700
| -4% | -$88.3K | ﹤0.01% | 3069 |
|
|
2020
Q1 | $1.43M | Sell |
1,064,553
-71,100
| -6% | -$232K | ﹤0.01% | 3190 |
|
|
2019
Q4 | $3.94M | Buy |
1,135,653
+53,700
| +5% | +$169K | ﹤0.01% | 2877 |
|
|
2019
Q3 | $3.33M | Sell |
1,081,953
-54,300
| -5% | -$161K | ﹤0.01% | 3041 |
|
|
2019
Q2 | $3.31M | Sell |
1,136,253
-68,647
| -6% | -$196K | ﹤0.01% | 2992 |
|
|
2019
Q1 | $3.21M | Sell |
1,204,900
-110,100
| -8% | -$340K | ﹤0.01% | 2966 |
|
|
2018
Q4 | $4.01M | Sell |
1,315,000
-171,400
| -12% | -$565K | ﹤0.01% | 2749 |
|
|
2018
Q3 | $5.87M | Buy |
1,486,400
+409,100
| +38% | +$1.51M | ﹤0.01% | 2604 |
|
|
2018
Q2 | $3.34M | Buy |
1,077,300
+177,600
| +20% | +$567K | ﹤0.01% | 3006 |
|
|
2018
Q1 | $2.29M | Buy |
899,700
+161,800
| +22% | +$454K | ﹤0.01% | 3173 |
|
|
2017
Q4 | $1.96M | Buy |
737,900
+327,800
| +80% | +$731K | ﹤0.01% | 3341 |
|
|
2017
Q3 | $964K | Buy |
410,100
+167,600
| +69% | +$515K | ﹤0.01% | 3537 |
|
|
2017
Q2 | $1.38M | Buy |
+242,500
| New | +$1.57M | ﹤0.01% | 3263 |
|
|
2016
Q2 | – | Sell |
-700
| Closed | -$2K | – | 5062 |
|
|
2016
Q1 | $2K | Sell |
700
-1,776
| -72% | -$5.09K | ﹤0.01% | 4524 |
|
|
2015
Q4 | $7K | Buy |
+2,476
| New | +$6.86K | ﹤0.01% | 4290 |
|
JP Morgan Chase's CRHM Position: Q2 2021 in Review
JP Morgan Chase sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 960,830 shares — an estimated $3.79M sold.
JP Morgan Chase first reported a position in CRHM in Q4 2015 and held it in 18 quarters. The position peaked at $5.87M in Q3 2018. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- JP Morgan Chase reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- JP Morgan Chase sold 960,830 CRH Medical Corporation shares in Q2 2021, an estimated $3.79M.
- JP Morgan Chase first reported a position in CRH Medical Corporation in Q4 2015 and held it in 18 quarters.
- JP Morgan Chase's CRH Medical Corporation position peaked at $5.87M in Q3 2018.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.